TRDV1 and melanoma: Furthermore, reanalysis of RNA sequencing data from the INSPIRE trial,74 evaluating the effect of pembrolizumab treatment across a variety of advanced solid cancers including melanoma, showed that higher than median TRDV1 expression in tumor biopsies was linked to prolonged OS.55